期刊文献+

正电子发射型断层成像技术对胃癌术前的诊断价值及临床意义 被引量:9

Preoperative diagnostic accuracy a nd clinical significance of positro n emission computed tomography in gastric cancer
原文传递
导出
摘要 目的评估正电子发射型断层成像(PET)技术在胃癌患者术前的诊断价值及临床意义。方法对21例胃癌患者术前进行PET全身显像分期和手术探查分期及病理分期对照,采用国际抗癌联盟(IUCC)公布的TNM分期标准,并进行χ2检验。结果PET对胃癌原发灶的显示率为100%,PET对淋巴结(N)分期的准确率为85.7%(18/21),术中探查对N分期准确率为75%(15/20),两组间经χ2检验差异无显著性意义(P>0.05)。PET图像显示了全部4例患者的远处组织器官转移病灶。结论PET对胃癌原发灶及其远处转移病灶的检测准确、敏感,能对胃癌诊断、手术方法和治疗原则的选择提供有价值的参考依据。 Objective To evaluate the preoperative diagnostic accuracy and clinical signific ance of positron emission tomography(PET)in gastric ancer.Methods Preoperative staging of gastric can cer by18-fluorodeoxyglucose positron em ission tomography(PET),and staging by exploratory laparotomy were performed on 21patients with gastric cancer,and the results were compared with postoperative pathological results respectively.Results The diagnostic accuracy of PET for pr imary loci of gastric cancer was 100%.The accuracy of PET and exploratory laparotomy for lymphatic node staging were 85.7%(18/21)and 75%(15/20)respectively.There was no signific ant difference between them(P>0.05).PET scanning identified the distant metastases i n all four patients.Conclusions PET scanning is accurate and sensiti ve to detect primary lesions and distan t metastases in gastric cancer.It can provide valuable reference on the diagnosis,choices of operative pro cedures and therapeutic principles in gastric cancer.[
出处 《中华胃肠外科杂志》 CAS 2003年第3期167-170,共4页 Chinese Journal of Gastrointestinal Surgery
基金 全军医药卫生科研基金课题(01MA095)
关键词 正电子发射型断层成像技术 胃癌 术前 诊断 临床意义 消化道肿瘤 Stomach neoplasms Tomography,emi ssion-computed Operation Diagnosis
  • 相关文献

参考文献11

  • 1Davies J, Chalmers AG, Sue-Ling HM, et al. Spiral computed tomography and operative staging of gastric carcinoma:a comparison with histopatholagical staging. Gut, 1997, 41: 314-319.
  • 2Rice TW. Clinical staging of esophageal carcinoma. CT, EUS,and PET. Chest Surg Clin N Am,2000,10: 471-485.
  • 3Saunders CA, Dussek JE, O'Doherty M J, et al. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg, 1999,67: 790-797.
  • 4Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum, 2000,43: 759-770.
  • 5Burr BM, Humm JL, Kooby DA, et al. Using positron emission tomography with ^18F-FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia, 2001,3: 189-195.
  • 6Davis PW, Perrier ND, Adler L, et al. Incidental thyroid carcinoma identified by positron emission tomography scanning obtained for metastatic evaluation. Am Surg, 2001,67: 582-584.
  • 7Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of eosophageal cancer with ^18f-fluorodeoxyglucose positron emission tomngraphy.AJR, 1997,168: 417-424.
  • 8Bender H, Palmedo H, Biersack H J, et al. Atlas of clinical PET in ontology: PET versus CT and MRI. New York: Springer Verlag,2000. 11.
  • 9McAteer D, Wallis F, Couper G, et al. Evaluation of ^18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br J Radiol, 1999,72: 525-529.
  • 10Ramdave S, Thomas GW, Berlangieri SU, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol, 2001,166: 825-830.

同被引文献55

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部